Accrued and other liabilities

12 Months Ended

Dec. 31, 2012

Accrued and other liabilities

Accrued and other liabilities

Note 6. Accrued and other liabilities

        Accrued and other liabilities consist of (in thousands):

	Balance as of
	December 31, 2012		December 31, 2011
Accrued research and clinical expenses	$	1,372	$	1,425
Accrued employee compensation and benefits		3,859		3,693
Accrued manufacturing costs		4,135		—
Accrued sales and marketing expenses		2,908		—
Other accrued liabilities		1,503		1,274
Total	$	13,777	$	6,392

        The amounts included in accrued and other liabilities consist of obligations for past services, primarily related to accrued manufacturing and product commercialization costs for services relating to past periods in support of the commercial launch of Qsymia in the U.S., accrued employee compensation and benefits, and accrued research and clinical expenses.